Evidence map›Paper›PMID 35493204›Full record

ArticleRSC advances2021

Preparative separation of 1,1-diphenyl-2-picrylhydrazyl inhibitors originating from

Jun Dang, Jianbin Ma, Yangzom Dawa, Chuang Liu, Tengfei Ji, Qilan Wang

Abstract read
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Separation of Antioxidants from Trace Fraction ofInternational journal of molecular sciences · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jun DangQinghai Provincial Key Laboratory of Tibetan Medicine Research, Key Laboratory of Tibetan Medicine Research, Northwest Institute of Plateau Biology, Chinese Academy of Sciences Xining Qinghai China wql@nwipb.cas.cn.
Jianbin MaQinghai Provincial Key Laboratory of Tibet Plateau Biodiversity Formation Mechanism and Comprehensive Utilization, College of Life Sciences, Qinghai Normal University Xining 810008 China.
Yangzom DawaQinghai Provincial Key Laboratory of Tibet Plateau Biodiversity Formation Mechanism and Comprehensive Utilization, College of Life Sciences, Qinghai Normal University Xining 810008 China.
Chuang LiuQinghai Provincial Key Laboratory of Tibetan Medicine Research, Key Laboratory of Tibetan Medicine Research, Northwest Institute of Plateau Biology, Chinese Academy of Sciences Xining Qinghai China wql@nwipb.cas.cn.
Tengfei JiState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College Beijing 100050 China jitf@imm.ac.cn.ORCID https://orcid.org/0000-0001-6168-3325
Qilan WangQinghai Provincial Key Laboratory of Tibetan Medicine Research, Key Laboratory of Tibetan Medicine Research, Northwest Institute of Plateau Biology, Chinese Academy of Sciences Xining Qinghai China wql@nwipb.cas.cn.ORCID https://orcid.org/0000-0003-4206-2587

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditional Tibetan medicines elaborately document the health benefits of

Identifiers

PMID35493204
PMCPMC9044138

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.